Better sleep, quicker recovery, a leaner build, aging well.
Those are the goals that bring most people to ask about CJC-1295 + Ipamorelin. At Alturas Medical Weight Loss in Meridian, Dr. Ashley Southern, NMD, starts with your goals and health history, then tells you plainly what this peptide pair is known to do, what it isn’t, and whether it makes sense for you.
Both peptides prompt your pituitary gland to release more of your body’s own growth hormone, through two different pathways. We review lab work before prescribing whenever it is medically appropriate, and every peptide we prescribe is made in the United States. Learn more about our peptide therapy in Boise.
Made in the USA
Every peptide we prescribe is made in the United States
CJC-1295 + Ipamorelin are synthetic peptides studied for their effects on growth hormone signaling. They act through different pathways involved in the body’s regulation of growth hormone.
The two compounds are often discussed together in wellness settings because they influence related pathways. However, evidence that the combination produces meaningful improvements in body composition, recovery, sleep, or other wellness outcomes remains limited.
Importantly, findings from studies of either compound individually do not establish the safety or effectiveness of using them together.
Choosing a clinic for peptide-related questions should involve more than the treatment itself. It should include an appropriate medical evaluation, a clear discussion of risks, and realistic expectations.
At Alturas Medical Weight Loss, our approach emphasizes:
Our clinic is located at 1532 W Cayuse Creek Dr in Meridian, Idaho, making us an option for people seeking medical consultations near Boise and throughout the Treasure Valley.
Research into these peptides is ongoing, but the evidence requires careful interpretation.
A clinical study published in the Journal of Clinical Endocrinology & Metabolism examined CJC-1295 in healthy adults. Researchers observed sustained increases in growth hormone and IGF-1 levels after administration. However, changes in hormone levels alone do not prove that a treatment improves long-term health, body composition, athletic performance, or quality of life.
Ipamorelin has also been investigated in human research, including studies examining its effects on growth hormone release and other clinical applications. These findings do not establish the benefits or safety of the CJC-1295 + Ipamorelin combination for general wellness.
The U.S. Food and Drug Administration (FDA) has identified safety concerns and limited safety data associated with compounded CJC-1295 + Ipamorelin. Neither compound should be assumed to be FDA-approved for anti-aging, muscle growth, recovery, or general wellness.
At Alturas, we believe patients deserve a clear distinction between established medical evidence, preliminary research, and claims that have not been adequately demonstrated in humans.
Sources
Where this information comes from
Last reviewed: October 2026
People seeking CJC-1295 + ipamorelin commonly encounter claims involving:
These are areas of interest in peptide-related discussions, but the claimed benefits are not established outcomes of the combined treatment. Evidence from early-stage research should not be interpreted as proof that the combination will deliver a particular result.
A medical consultation can help you discuss your goals, review your health history, and consider whether established diagnostic or treatment options are more appropriate.
Peptides that influence growth hormone pathways can affect hormone signaling and may have risks that are not fully understood. The safety profile may depend on the specific compound, formulation, route of administration, and individual health factors.
The FDA has raised concerns about compounded CJC-1295, including reports of increased heart rate and systemic vasodilatory reactions. For ipamorelin, the agency has identified potential immunogenicity and peptide-impurity concerns, along with insufficient safety information for certain injectable uses.
Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, and quality before marketing in the same way it reviews approved drugs. A prescription or pharmacy relationship does not eliminate these uncertainties.
Patients should disclose their medications, supplements, medical conditions, and relevant history to their clinician. Do not use products marketed as “research peptides” or self-administer injectable peptides without appropriate medical guidance.
Alturas Medical Weight Loss serves patients seeking individualized medical weight loss, hormone-related care, and information about peptide-based treatments.
Patients come to our Meridian clinic from all over the Treasure Valley. Some live right here in Meridian, and many drive in from Boise, Eagle, Nampa, Star, Middleton, Kuna, Caldwell and Garden City.
Rather than assuming a particular peptide is appropriate, our approach starts with understanding your goals and determining which options warrant medical consideration.
Location: 1532 W Cayuse Creek Dr, Meridian, ID 83646
Phone: (208) 690-2040
Contact Alturas Medical Weight Loss to ask about consultation availability and discuss your health goals with our team.
Dr. Ashley Southern is the physician and co-founder of Alturas Medical Weight Loss. She evaluates peptide therapy within the context of each patient’s medical history, medications and laboratory results.
The goal is to determine whether a specific therapy is medically appropriate.
CJC-1295 + Ipamorelin is one of several peptides our team discusses at our Meridian clinic, near Boise. Every plan starts with a medical evaluation. Explore our full peptide therapy in Boise program or the related therapies below.
A GHRH analog studied for its effects on visceral adipose tissue and body composition.
Bremelanotide, which acts on melanocortin receptors in the brain. The FDA-approved version (Vyleesi) is approved for low sexual desire in premenopausal women; other uses are off-label.
A peptide that has been studied, mostly in animal research, for tendon, ligament and gut-lining repair. Used in certain physician-supervised recovery protocols.
An investigational peptide fragment of thymosin beta-4, studied primarily in laboratory research involving tissue repair and wound healing.
A combination of BPC-157 and TB-500 considered in physician-supervised recovery protocols.
Alturas Medical Weight Loss is located in Meridian, Idaho, near Boise. Our team provides consultations to discuss health goals, medical history, available evidence, and potential treatment options.
CJC-1295 is a synthetic GHRH analog, while ipamorelin is a growth hormone secretagogue. Both are studied for their effects on growth hormone signaling, but their combined use has limited clinical evidence for many wellness-related claims.
The combination is not an FDA-approved treatment for anti-aging, muscle growth, recovery, or general wellness. Compounded products are not FDA-approved, and the FDA has raised safety concerns about both compounds.
These compounds are frequently marketed for muscle development and recovery, but strong clinical evidence demonstrating these outcomes from the combined treatment is lacking. Individual results and safety cannot be reliably predicted from current evidence.
Yes. A clinician can review your medical history, discuss known and uncertain risks, evaluate potential alternatives, and determine whether further testing is appropriate. Medical supervision does not remove all risks, particularly when evidence is limited.
Call Alturas Medical Weight Loss at (208) 690-2040 to ask about consultations at our Meridian clinic.
Rather than assuming a particular peptide is appropriate, our approach starts with understanding your goals.
Call (208) 690-2040 to ask about consultations at our Meridian clinic, near Boise.
For men and women
Recovery, energy and wellness
